Transforming Molecules into Medicines: Role of CDMOS in Phase-Appropriate Technology Transfers in Advancing Pharmaceutical Innovation

ISSN Print: 2160-0392
ISSN Online: 2160-0406
www.scirp.net/journal/aces
E-mail: [email protected]

Citations

"Transforming Molecules into Medicines: Role of CDMOS in Phase-Appropriate Technology Transfers in Advancing Pharmaceutical Innovation"
written by Kishore Kumar Hotha,
published by Advances in Chemical Engineering and Science, Vol.13 No.3, 2023

has been cited by the following article(s):

[1]	Antibody-Drug Conjugates (ADCs): Navigating Four Pillars of Safety, Development, Supply Chain and Manufacturing Excellence
	Advances in Chemical Engineering and Science, 2023

[2]	The ABC of ADCs (Antibody-Drug Conjugates): A Comprehensive Review of Technical, Regulatory, and Clinical Challenges
	Advances in Chemical Engineering and Science, 2023

[1]	A Preliminary Study on the Key Factors of Biopharmaceutical CDMO Ecosystem Development and Digital Resilience Building 2024 IEEE International Conference on Industrial Engineering and Engineering Management (IEEM), 2024 DOI:10.1109/IEEM62345.2024.10857245

[2]	Fast-to-Clinic, Fast-to-Market in Biotech Innovation: Optimizing Chemistry Manufacturing & Controls (CMC) Excellence for Clinical and Commercial Success Advances in Chemical Engineering and Science, 2024 DOI:10.4236/aces.2024.143010

[3]	The ABC of ADCs (Antibody-Drug Conjugates): A Comprehensive Review of Technical, Regulatory, and Clinical Challenges Advances in Chemical Engineering and Science, 2023 DOI:10.4236/aces.2023.134025

[4]	Antibody-Drug Conjugates (ADCs): Navigating Four Pillars of Safety, Development, Supply Chain and Manufacturing Excellence Advances in Chemical Engineering and Science, 2023 DOI:10.4236/aces.2023.134024